... of blood relatives with prostate cancer and young age at onset of prostate cancer within families.[ 28 ] There is considerable controversy in prostate cancer about the use of serum prostate-specific antigen (PSA) measurement and digital rectal exam for prostate cancer early ...

... and 36.4 for African American men.[ 2 ] Age-adjusted incidence rates increased steadily from 1975 through 1992, with particularly dramatic increases associated with the inception of widespread use of prostate-specific antigen (PSA) screening in the late 1980s and early ...

... as other PSA-based prognostic measures, such as age-adjusted thresholds, velocity, and ... “early diagnosis,” “PSA velocity,” “PSA doubling time,” and “ ...

... of tumor . Histologic grade of tumor . Patient's age and health . Prostate-specific antigen (PSA) level . (Refer to the Surveillance, Epidemiology, and ... of this summary for more information.) Patient's age and health Any benefits ... antigen (PSA) level PSA, an organ-specific marker, is ...

... variants.[ 424 , 462 ] Notwithstanding prevalent controversy surrounding routine prostate-specific antigen (PSA) screening, the authors suggested that screening by means of PSA and digital rectal exam beginning at age 40 years in male MMR gene carriers would ...

... predictors of time to cancer specific death after prostate specific antigen failure. J ... and survival in men of advanced age with node-negative high-risk adenocarcinoma of the ...

... PG, Kattan MW, Mottet N, et al. Using prostate specific antigen screening and nomograms to assess risk and predict ... H. Economic evaluation of prostate cancer screening with prostate specific antigen. International Journal of Urology. 2008 Apr; 15 (4): ...

... concerning imaging studies for lung cancer, and elevated prostate-specific antigen for prostate cancer. Delayed diagnostic evaluation was defined by the ...

... the recent European [ 250 ] and North American [ 251 ] prostate-specific antigen (PSA) screening trials after comparable follow-up. The data have been more limited in BRCA1 -associated prostate cancers, however a number of recent studies have ...